Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Centro De Investigaciones Energéticas Medioambientales Y Tecnológicas O A M P (Ciemat) is currently overseeing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner, which centralizes the current dialogue with the patent office. Furthermore, the portfolio is active within 1 distinct art unit, indicating a focused administrative presence. This structure avoids the complexity of managing multiple examiners or different art unit standards.
The busiest examiner for this portfolio is SALMON, KATHERINE D, who is responsible for 1 pending office action. Given that the total number of pending actions is 1, this examiner is managing the entirety of the current active prosecution. This direct relationship allows the applicant to focus their legal strategy on the specific tendencies of SALMON, KATHERINE D. The alignment of 1 pending action with 1 examiner and 1 art unit suggests a streamlined path for the intellectual property development. Practitioners should prioritize understanding the specific examination style of this examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SALMON, KATHERINE D | 1 | 42.9% | +37.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907315 | BIOMARKERS FOR PREDICTING A PATIENT'S RESPONSE TO BCG THERAPY, METHODS AND USES BASED THEREON | SALMON, KATHERINE D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907315 | BIOMARKERS FOR PREDICTING A PATIENT'S RESPONSE TO BCG THERAPY, METHODS AND USES BASED THEREON | SALMON, KATHERINE D | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17907315 | BIOMARKERS FOR PREDICTING A PATIENT'S RESPONSE TO BCG THERAPY, METHODS AND USES BASED THEREON | SALMON, KATHERINE D | 1682 | §101§102§112 | Non-Final OA | — | Pending | Sep 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentro De Investigaciones Energéticas Medioambientales Y Tecnológicas O A M P (Ciemat) has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Katherine D Salmon has the most, with 1 of Centro De Investigaciones Energéticas Medioambientales Y Tecnológicas O A M P (Ciemat)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
